Skip to main content

Study M951

Study name

Lei CF 2022

Title

Integrating metabolomics and network analysis for exploring the mechanism underlying the antidepressant activity of paeoniflorin in rats with CUMS-induced depression

Overall design

In this study, a combination of network pharmacology and LC-MS-based untargeted metabolomics was employed to explore urinary biomarkers of paeoniflorin in the chronic unpredictable mild stress (CUMS) model of depression. Sprague-Dawley rats were divided into the following 3 groups (n = 8 in each group): (1) control group, (2) CUMS group, and (3) CUMS + paeoniflorin group (stressor plus paeoniflorin treatment at the dose of 10 mg/kg). The CUMS stress procedure lasted for 6 weeks, and drugs were administered via intragastric once per day during the last 3 weeks of model building period. A urinary metabolomics method was applied to evaluate the efficacy of paeoniflorin. Eight samples per group were used for metabonomic analysis.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Sucrose preference test

Sample size

24

Tissue

Peripheral; Urine; Urine;

Platform

MS-based; LC-MS: UHPLC-QExactiveHF-X system (Thermo Fisher Scientific);

PMID

35770096

DOI

10.3389/fphar.2022.904190

Citation

Lei C, Chen Z, Fan L, et al. Integrating metabolomics and network analysis for exploring the mechanism underlying the antidepressant activity of paeoniflorin in rats with CUMS-induced depression. Front Pharmacol. 2022 Jun 13;13:904190.

Metabolite

Citric acid;

5-Hydroxyindoleacetic acid;

Thiamine monophosphate;

Sumiki's acid;

Gluconolactone;

Quinone;

Erucamide;

12-oxo-5E,8E,10Z-dodecatrienoic acid;

(+/-)-Hexanoylcarnitine;

Blumenol C glucoside;

D-(+)-dihydrocarvone;

S-Nitrosoglutathione;

Biopterin;

3-carboxy-4-methyl-5-pentyl-2-furanpropanoic acid;

Alanylproline;

Tranylcypromine glucuronide;

(Z)-3-Oxo-2-(2-pentenyl)-1-cyclopenteneacetic acid;

3-Hydroxytetradecanedioic acid;

O-Desmethylvenlafaxine glucuronide;

10-Hydroxymyoporone;

N-Acetyltyramine;

Tsangane L 3-glucoside;

p-Isoamylphenol;

Trigoforin;

5-Nitro-2-(3-phenylpropylamino)benzoic acid;

3,8-Dihydroxy-6-methoxy-7(11)-eremophilen-12,8-olide;

Erysonine;

4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid;

2,6-Dioxo-6-phenylhexanoate;

Ethanethioic acid;

(5R)-5-Hydroxyhexanoic acid;

5-Hydroxy-2-(5-methyl-1-oxo-4-hexenyl)benzofuran;

5'-Deoxyadenosine;

4-Hydroxy-5-(phenyl)-valeric acid-O-sulphate;

beta-D-Glucopyranosyl-11-hydroxyjasmonic acid;

Valproic acid glucuronide;

{[1-(4-methoxyphenyl)-4-methylpent-1-en-3-yl]oxy}sulfonic acid;

xi-3-Hydroxy-5-phenylpentanoic acid O-beta-D-Glucopyranoside;

alpha-CEHC glucuronide;

6-(4-ethyl-2-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid;

1,4-Ipomeadiol;

3,4,5-trihydroxy-6-[(2-hydroxy-2-methylpropanoyl)oxy]oxane-2-carboxylic acid;

Mellein;

1-(Malonylamino)cyclopropanecarboxylic acid;

{[1-(2-hydroxyphenyl)-3-oxopropan-2-yl]oxy}sulfonic acid;

6-{4-[(1E)-3-[(3-carboxy-5,6-dihydroxycyclohex-3-en-1-yl)oxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid;

2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethan-1-ol;

Dihydromaleimide beta-D-glucoside;

Cis-2,3-Dihydroxy-2,3-dihydro-p-cumate;

Veranisatin A;

2-Methoxyhydroquinone;

N-(2-Hydroxyethyl)iminodiacetic acid;

Stachyose;

9,15-dioxo-11R-hydroxy-2,3,4,5-tetranor-prostan-1,20-dioic acid;

{4-[(E)-2-{3,5-dihydroxy-4-[(1E)-3-methylbuta-1,3-dien-1-yl]phenyl}ethenyl]phenyl}oxidanesulfonic acid;

Trans-Chlorogenic acid;